SBFM FY 2019 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$21,121-95.3% YoY

Gross Profit

$10,07147.7% margin

Operating Income

-$641,636-3037.9% margin

Net Income

-$2M-7860.9% margin

EPS (Diluted)

$-18866.94

Cash Flow

Operating Cash Flow

-$495,798

Free Cash Flow

-$496,658

Stock-Based Comp.

$261,689

Balance Sheet

Total Assets

$98,142

Total Liabilities

$833,527

Stockholders' Equity

-$735,385

Cash & Equivalents

$40,501

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,121	$447,200	-95.3%
Gross Profit	$10,071	$56,119	-82.1%
Operating Income	-$641,636	-$1M	+45.0%
Net Income	-$2M	-$2M	+23.0%